Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Activo, no recluta
Fase 3
ClinicalTrials.gov
The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis
INTERVENTIONAL
Inicio: 1 de abr de 2021
ID: NCT04822181
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
INTERVENTIONAL
Inicio: 13 de mar de 2024
ID: NCT06318169
Completado
Fase 4
ClinicalTrials.gov
Study ACA-ARGE-04-001 "A Pilot, Open-Label Study Assessing Safety, Tolerability, Efficacy of a Simplified Lopinavir/Ritonavir Induction/Maintenance Therapy in HIV-Infected Subjects on Their First Protease Inhibitor-Based Regimen".
INTERVENTIONAL
Inicio: 1 de abr de 2005
ID: NCT00159224
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 2/3, Multicenter, Open-label, Multicohort Study Evaluating Pharmacokinetics (PK), Safety, and Efficacy of Cobicistat-boosted Atazanavir (ATV/co) or Cobicistat-boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in HIV-1 Infected, Virologically Suppressed Pediatric Participants
INTERVENTIONAL
Inicio: 16 de ene de 2014
ID: NCT02016924
Completado
ClinicalTrials.gov
Tocilizumab for Treatment of SARS Cov2 Pneumonia. Experience in a Private Health Center Facility in Buenos Aires City.
OBSERVATIONAL
Inicio: 1 de jul de 2021
ID: NCT05057962
Completado
Fase 4
ClinicalTrials.gov
An Open-Label, Non-Comparative Study to Assess the Pharmacokinetics, Safety and Efficacy of Topical Retapamulin (SB-275833) Ointment, 1%, Twice Daily for Five Days in the Treatment of Uncomplicated Skin and Skin Structure Infections in Pediatric Subjects Aged 2 to 24 Months
INTERVENTIONAL
Inicio: 1 de sept de 2007
ID: NCT00555061
Completado
Fase 1
ClinicalTrials.gov
Phase I Clinical Trial of a Therapeutic Vaccine Composed of Autologous Dendritic Cells Loaded With Allogeneic Apoptotic Tumor Cells in Patients With Melanoma Stages IIB, IIC, III and IV
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00515983
Completado
ClinicalTrials.gov
Prospective Observational Study of Site-Specific Incident and Prevalent Cases of Cancer in People Living With HIV/AIDS- in Latin America
OBSERVATIONAL
Inicio: 17 de ene de 2020
ID: NCT04089488
Completado
ClinicalTrials.gov
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
OBSERVATIONAL
Inicio: 1 de jun de 2012
ID: NCT01598779
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Active Controlled Noninferiority Study Evaluating the Efficacy, Safety, and Tolerability of Cefepime/VNRX-5133 in Adults With Complicated Urinary Tract Infections (cUTI), Including Acute Pyelonephritis
INTERVENTIONAL
Inicio: 7 de ago de 2019
ID: NCT03840148
Completado
Fase 3
ClinicalTrials.gov
Ivermectin to Prevent Hospitalizations in COVID-19: Randomized, Double-blind, Placebo-controlled
INTERVENTIONAL
Inicio: 19 de ago de 2020
ID: NCT04529525
Completado
Fase 2
ClinicalTrials.gov
A Phase 2B Multicenter, Randomized, Double-Blind, Comparative Trial Of UK-453,061, In Combination With Tenofovir Df And Emtricitabine Versus Efavirenz In Combination With Tenofovir DF And Emtricitabine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de feb de 2009
ID: NCT00824421
Completado
Fase 2
ClinicalTrials.gov
A Randomized Phase 2b Trial Evaluating Clinical Outcomes of Inhaled Sargramostim in High-risk Patients With Mild-moderate COVID-19
INTERVENTIONAL
Inicio: 27 de abr de 2021
ID: NCT04707664
Completado
Fase 3
ClinicalTrials.gov
Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia
INTERVENTIONAL
Inicio: 18 de abr de 2020
ID: NCT04535063
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Phase 2 Study to Evaluate the Efficacy and Safety of BMS-986263 in Adults With Compensated Cirrhosis From Nonalcoholic Steatohepatitis (NASH)
INTERVENTIONAL
Inicio: 17 de mar de 2021
ID: NCT04267393
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-blind, Active Controlled Study to Compare the Efficacy and Safety of Ridinilazole (200 mg, Bid) for 10 Days With Vancomycin (125 mg, Qid) for 10 Days in the Treatment of Clostridium Difficile Infection (CDI)
INTERVENTIONAL
Inicio: 28 de ene de 2019
ID: NCT03595553
Por invitación
ClinicalTrials.gov
Mass Screening for Chagas Disease Among University Entrants as a Strategy to Improve Access to Diagnosis and Treatment in the Province of Salta, Argentina
OBSERVATIONAL
Inicio: 11 de sept de 2024
ID: NCT07033325
Completado
ClinicalTrials.gov
Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2.
INTERVENTIONAL
Inicio: 4 de jun de 2020
ID: NCT04479163
Completado
ClinicalTrials.gov
International GBS Outcome Study (IGOS): a Prospective INC Study on Clinical and Biological Predictors of Disease Course and Outcome in Guillain-Barré Syndrome (GBS).
OBSERVATIONAL
Inicio: 1 de may de 2012
ID: NCT01582763
Completado
Fase 2
ClinicalTrials.gov
A Phase IIb Randomized, Controlled, Partially-Blinded Trial to Investigate Safety, Efficacy and Dose-Response of BMS-663068 in Treatment-experienced HIV-1 Subjects, Followed by an Open-Label Period on the Recommended Dose
INTERVENTIONAL
Inicio: 26 de jul de 2011
ID: NCT01384734
Anterior
1
...
31
32
33
...
434
Siguiente
Filtros